Table 1.
Basic demographic, clinical, and echocardiographic data as well as selenium levels of heart failure and control groups*
| Heart Failure (n=77) | Control (n=73) | P value** | |
|---|---|---|---|
| Age (y) | 68.4±10.4 | 64.9±4.7 | 0.02 |
| Female | 31 (40.3) | 26 (35.6) | 0.55 |
| Weight | 67.1±13.6 | 66.5±5.0 | 0.77 |
| Height | 165.2±9.2 | 166.7±7.5 | 0.32 |
| BMI | 24.4±3.7 | 24.0±2.2 | 0.46 |
| HLP | 18 (25.4) | - | < 0.01 |
| DM | 15 (18.3) | - | < 0.01 |
| SBP | 136.4±29.1 | 129.2±7.5 | 0.04 |
| DBP | 81.3±15.4 | 72.4±6.6 | < 0.01 |
| HR | 92.0±21.4 | 72.1±4.7 | < 0.01 |
| LAA | 28.5±8.2 | 19.5±1.1 | < 0.01 |
| LVDD | 61.9±8.9 | 49.8±1.5 | < 0.01 |
| LVSD | 52.4±8.7 | 31.4±2.3 | < 0.01 |
| LVEF | 25.2±6.3 | 54.3±2.6 | < 0.01 |
| Selenium | 185.9±781.2 | 123.3±115.5 | 0.49 |
*
Data are presented as mean±SD or n (%)
**
P value (independent samples t-test, and Chi-Square for quantitative and qualitative variables, respectively)
BMI, Body mass index; HLP, Hyperlipidemia; DM, Diabetes mellitus; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; HR, Heart rate; LAA, Left atrium area; LVDD, Left ventricle diastolic diameter; LVSD, Left ventricle systolic diameter; LVEF, Left ventricle ejection fraction